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A uniform cloning platform for 
mycobacterial genetics and protein 
production
Fabian M. Arnold1, Michael Hohl  1,2, Sille Remm1, Hendrik Koliwer-Brandl1, Sophia Adenau1, 
Sasitorn Chusri1,3, Peter Sander1, Hubert Hilbi  1 & Markus A. Seeger  1
Molecular research on mycobacteria relies on a multitude of tools for the genetic manipulation of 
these clinically important bacteria. However, a uniform set of vectors allowing for standardized 
cloning procedures is not available. Here, we developed a versatile series of mycobacterial vectors for 
gene deletion, complementation and protein production and purification. The vectors are compatible 
with fragment exchange (FX) cloning, a recently developed high-throughput cloning principle taking 
advantage of the type IIS restriction enzyme SapI and its capacity to generate sticky trinucleotide ends 
outside of its recognition sequence. FX cloning allows for the efficient cloning into an entry vector and 
the facile transfer of the sequenced insert into a variety of destination vectors. We generated a set of 
mycobacterial expression vectors spanning a wide range of expression strengths, tagging variants and 
selection markers to rapidly screen for the optimal expression construct in order to purify membrane 
proteins from the model organism Mycobacterium smegmatis. Further, we generated a series of suicide 
vectors containing two counterselection markers and used them to delete twenty genes encoding for 
potential drug efflux pumps in M. smegmatis. The vectors will further facilitate genetic and biochemical 
research on various mycobacterial species.
The genus Mycobacterium includes pathogens that cause serious diseases in humans, including Mycobacterium 
tuberculosis, the causative agent of tuberculosis. Tuberculosis is one of the world’s most lethal diseases, infecting 
about one-third of the world’s population and killing around two million people every year1. Genetic manipula-
tion of mycobacteria was essential to discover and study cellular processes responsible for virulence and resist-
ance at the molecular level. The last three decades have brought about an impressive number of genetic tools and 
vectors for the deletion or downregulation of mycobacterial genes2–9. However, each of the vectors has its own 
multiple cloning site, which imposes an obstacle to test different selection markers in parallel. If a gene deletion is 
conducted, the upstream and downstream homology sequences flanking the target gene (called flanking regions 
within this manuscript) are usually cloned in two separate steps using different combinations of type I restriction 
enzymes, which requires adapting the cloning strategy for each gene deletion construct. A notable exception is 
a recently published procedure based on the restriction enzyme Van91I, which allows cloning of the flanking 
regions in a single step9.
Non-pathogenic and fast-growing M. smegmatis has emerged as an important expression host for genes orig-
inating from mycobacterial species including M. tuberculosis10–14. The rationale behind using M. smegmatis as 
expression host is three-fold: (i) mycobacteria have a very high genomic GC content and thus a different codon 
usage as common expression hosts such as Escherichia coli, (ii) the cytoplasm of M. smegmatis contains cognate 
heat shock and other stress-induced proteins, which may improve the proper folding of produced proteins and 
(iii) the cytoplasmic membrane and in particular the mycobacterial outer membrane has a lipid composition 
distinct from any other commonly used expression host, which is of high relevance if one aims to produce myco-
bacterial membrane proteins. The production and purification of mycobacterial membrane proteins is there-
fore very challenging, which is reflected in a comparatively low number of biochemical and structural studies 
involving purified mycobacterial transporters, channels and other transmembrane proteins15–18. In the field of 
mycobacteria, three major types of expression vectors have emerged, which exhibit various expression strengths: 
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constitutive expression systems under the strong mycobacterial hsp60 promoter19, and inducible systems based on 
the tetracycline system10, the acetamide promoter13, the lac promoter20 and a riboswitch-based translational con-
trol21. The expression strength can be further modulated by using replicating multicopy plasmids containing the 
mycobacterial origin of replication (oriM)22 or integrative plasmids which are integrated into the chromosome 
as a single copy via attP/attB recombination23. However, a simple cloning scheme, which would allow inserting 
ORFs fused to different tagging variants for detection (e.g. GFP) and purification (e.g. His-tag) into mycobacterial 
expression vectors covering a wide range of expression strengths is currently lacking.
With the aim to study mycobacterial membrane transporters at the structural and functional level, we built an 
efficient cloning, expression and gene deletion platform based on the FX cloning method. The major advantage 
of FX cloning is that it facilitates fast and efficient cloning of ORFs into desired expression vectors by a robust 
and simple protocol based on the type IIS restriction enzyme SapI or its isoschizomers. The method proved to be 
highly efficient in finding optimal expression constructs in E. coli, Lactococcus lactis and other prokaryotic and 
eukaryotic expression hosts24,25. We constructed mycobacterial FX vectors for i) production and purification of 
(membrane) proteins using M. smegmatis as expression host, ii) fast and robust gene deletion in mycobacterial 
species, iii) complementation of deletion mutants in the absence of inducer and antibiotics and iv) conditional 
knockdown based on the pristamycin system. The platform was validated by the expression of an array of myco-
bacterial membrane transporters in M. smegmatis and by the generation of a large number of unmarked gene 
deletions in M. smegmatis and Mycobacterium marinum.
Results
Overview of the FX-vectors for mycobacterial genetics and protein production. The vectors in 
this work can be summarized into four main categories: inducible expression vectors for protein purification, 
constitutive expression vectors for complementation, conditional knockdown vectors and suicide vectors to gen-
erate unmarked gene deletions via two-step recombination (Fig. 1). All vectors are fully compatible with the FX 
cloning method24, permitting the rapid transfer of mycobacterial ORFs or flanking regions from a single entry 
vector into the respective mycobacterial destination vectors (Fig. 1). In a first step, ORFs are amplified via PCR 
with appropriate SapI overhangs and cloned into entry vector pINIT in a one-tube reaction including a restriction 
Figure 1. Overview of the mycobacterial FX cloning system. The vectors can be divided into four categories: 
inducible vectors for protein production and purification, constitutive vectors for gene complementation, 
vectors for gene deletions and vectors for conditional knockdowns. Open reading frames or flanking homology 
regions are first cloned into the entry vector pINIT, sequenced, and then transferred by backbone exchange into 
the mycobacterial destination vectors, which all contain an E. coli origin of replication for plasmid propagation.
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and a ligation step (Fig. 2A). In order to clone flanking regions into mycobacterial suicide vectors for targeted 
gene deletions by homologous recombination, two PCR fragments encompassing the upstream and downstream 
homology sequences are cloned in a three-fragment ligation step into the pINIT backbone as summarized in 
Fig. 2B. The flanking regions feature an additional SapI cleavage site resulting in a CCT sticky end located at the 3′ 
and 5′ ends of the upstream and downstream flanking region, respectively, thereby creating an additional unique 
ligation site. Because of the directionality of the SapI cleavage, the recognition site is lost and only the codon CCT 
remains as a minimal cloning scar. Upstream flanking regions used for conditional knockdowns follow the same 
cloning procedure as ORFs for gene expression. Analytical restriction digests are performed to identify positive 
pINIT clones, which are then confirmed by sequencing. Genetic material of correct pINIT clones can be stored 
and amplified in this vector, and ORFs as well as homology sequences are subsequently transferred into the 
desired mycobacterial destination vector by fragment exchange without the need of any further PCR reaction 
(Fig. 2C). Thereby a major source of introducing unwanted mutations to the cloned sequence is eliminated. A 
detailed list of all plasmids with information about resistance cassettes and plasmid functionalities is given in 
Table 1.
Protein production using the inducible vectors pMINT, pMEX and pACE. To be able to screen for 
the most suitable production level of a protein (and in particular a membrane protein), our aim was to construct 
vectors with low, medium and high gene expression levels. Additionally, we aimed for different tagging variants 
and resistance markers. To achieve this goal, we cloned the vector series pMINT, pMEX and pACE, which all 
can be replicated in E. coli for cloning purposes and plasmid amplification. The pMINT series is based on the 
tetracycline expression system10 and contains the phage L5 attP site and integrase for site-specific recombina-
tion with the attB site on the mycobacterial chromosome23, which allow for a controlled, low-level expression 
of proteins. The pMEX series is also based on the same tetracycline expression system, but comprises multicopy 
vectors harboring a mycobacterial origin of replication (oriM), thereby conferring higher expression levels than 
the pMINT vectors10. The episomal pACE vectors are based on the stronger acetamide promotor, allowing for 
the highest production level of proteins13. An overview of these vectors with their different tags and resistance 
markers is given in Fig. 3A. The tetracycline system, on which pMINT and pMEX are based, was described to 
be very tight10. To test pMINT and pMEX in M. smegmatis and assess the production level difference between 
pMINT and pMEX we chose a designed ankyrin repeat protein (DARPin), which is a stable soluble protein 
produced at high levels in E. coli26. The DARPin gene was cloned first into the pINIT vector and then transferred 
by FX cloning into pMINTC3GH and pMEXC3GH, thereby attaching a 3 C protease cleavage site, GFP and a 
His10-tag to the C-terminus. The DARPin constructs were then expressed overnight in M. smegmatis at varying 
concentrations of anhydrotetracycline (ATc). The quantification of production levels via in gel fluorescence of 
the GFP-fusion protein shows that the expression can be titrated with both vectors over a broad range of ATc 
concentrations (Fig. 3B). The replicative pMEX construct allows for higher production at cost of a higher basal 
production level. To test production of challenging proteins, four mycobacterial ORFs encoding for membrane 
transporters were cloned via entry vector pINIT into the destination vectors pMINTC3GH and pMEXC3GH, 
again attaching (cytoplasmatically located) GFP to the C-termini of these ORFs. The transporters were pro-
duced overnight in M. smegmatis by adding 100 ng/ml ATc and protein production was assessed again by in gel 
fluorescence of the GFP-fusion proteins (Fig. 3C). All transporters were produced as indicated by the fluores-
cent band at the expected height corresponding to the respective transporter-GFP fusion. Of note, GFP fluores-
cence indicates proper folding of the membrane proteins, because it only folds correctly if the fused membrane 
protein is correctly folded as well27. With the exception of MSMEG_0017/18, pMEX constructs produced to a 
higher level than the respective pMINT constructs. The non-induced pMEX control cultures did not exhibit any 
detectable recombinant protein production, indicating that these vectors are sufficiently tight for the produc-
tion of membrane proteins without risking toxicity problems. Finally, we tested production of two transporters 
with the pACE vector. We chose the major facilitator superfamily (MFS) transporter Rv1410, as well as the het-
erodimeric ABC exporter MSMEG_6553/54. We performed an overnight expression with 0.4% acetamide for 
induction, and analyzed protein production by in gel fluorescence of the transporter-GFP fusion. In parallel, we 
performed the expression with the respective pMINTC3GH and pMEXC3GH constructs induced with 200 ng/ml 
ATc. The in gel fluorescence analysis showed, that for both transporter proteins markedly higher production lev-
els were achieved with the pACEC3GH construct (Fig. 3D). To investigate whether the production levels using 
the pACE constructs were high enough for preparative-scale purification, the GFP-tagged membrane proteins 
Rv1410 and MSMEG_6553/54 were produced in 9 and 4.5 liter of 7H9 medium, respectively. The cells were lysed, 
the membrane fraction was harvested by ultracentrifugation, and the membrane transporters were extracted 
using the detergent n-dodecyl-β-D-maltopyranoside (β-DDM) and purified using Ni2+-NTA chromatography 
via the C-terminal His10-tag. Subsequently, GFP-His10 was cleaved off using 3 C protease and removed in a reverse 
Ni2+-NTA chromatography step (a schematic overview of the purification is given in Fig. 3E). Finally, untagged 
protein was polished by size exclusion chromatography (SEC) and eluted as single, monodisperse peak at a reten-
tion volume corresponding to the monomer in case of Rv1410 or a heterodimer in case of MSMEG_6553/54 
(Fig. 3F). The protein yields were 1 mg/batch and 0.8 mg/batch for Rv1410 and MSMEG_6553/54, respectively, 
and the transporters were highly pure as judged from SDS-PAGE analysis (Fig. 3G).
Complementation vector pFLAG. In functional studies, gene deletion mutants usually need to be com-
plemented with the wildtype gene in trans to demonstrate that the genetic manipulation exclusively affected the 
targeted gene as indicated by a reversion of the phenotype. An ideal complementation vector (i) exhibits a moder-
ate promoter strength to avoid toxicity effects from overexpression, (ii) contains a constitutive promoter and thus 
functions in the absence of inducers, (iii) is stably integrated as a single copy on the genome even in the absence 
of selective pressure and (iv) fuses a short tag to the complemented ORF to enable highly sensitive detection 
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of protein production. To meet these requirements, we generated pFLAG_attP. It harbors the tet-promoter as 
pMINT, but lacks the tet  repressor gene, rendering the promoter constitutively active at a moderate level. The 
plasmid further contains an attP site for chromosomal integration, but lacks the integrase gene, which allows for 
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Figure 2. The FX cloning principle. (A) Cloning of open reading frames (ORFs). ORFs are PCR amplified from 
genomic DNA using primers containing SapI overhangs. The purified PCR product is mixed with the pINIT 
vector containing the ccdB killer gene between its SapI restriction sites. Killer gene resistant E. coli DB3.1 is 
used to propagate pINIT_ccdB. The mixture is digested with SapI, thereby producing sticky AGT and GCA 
ends. Upon inactivation of SapI, the fragments are ligated in the same reaction mixture. Only clones containing 
the ORF as insert survive, while clones harboring back-ligation products containing the ccdB killer gene are 
not viable. (B) Cloning of two flanking regions in one step. SapI cleavage is used to introduce the additional 
sticky end CCT to clone the upstream and downstream flanking regions in a three-fragment ligation reaction 
into the pINIT backbone. (C) Transfer of inserts from pINIT into mycobacterial destination vectors by 
backbone exchange. The entry vector pINIT harbors a chloramphenicol resistance marker which is absent on 
the mycobacterial destination vectors. In a single reaction, entry vector pINIT containing an ORF or flanking 
regions and the destination vector containing the ccdB killer gene are digested with SapI, followed by ligation, 
transformation into E. coli and plating using the resistance marker of the destination vector (hygromycin, 
kanamycin or apramycin). Note that the SapI restriction sites are directed inversely in the destination vectors 
and therefore disappear after cloning of ORFs or flanking regions.
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stable integration of pFLAG_attP into the mycobacterial genome if the integrase gene is provided on a separate 
suicide vector in trans28. Finally, pFLAG_attP fuses a triple FLAG-tag (3xFLAG) to the C-terminus of cloned 
ORFs (Fig. 4A), enabling the highly sensitive detection of protein production even from minute amounts of bac-
terial cells by Western blotting. To demonstrate the utility of the 3xFLAG-tag, we transferred the gene encoding 
M. tuberculosis Rv1410 from the pINIT vector into pFLAG_attP using FX cloning. The resulting vector was prop-
agated in E. coli and then electroporated into M. smegmatis by co-electroporation in trans with the L5 bacterio-
phage integrase present on the suicide vector pMA_Int, which can neither replicate nor integrate in mycobacteria. 
Stable integrants were obtained by selecting on apramycin plates and confirmed by colony PCR. One integrant 
was grown to stationary phase in the presence or absence of apramycin, and a two-fold dilution series of total 
protein from a small amount of cells was separated by SDS-PAGE and analyzed by Western blotting for produc-
tion using an anti-FLAG antibody (Fig. 4B). Production of Rv1410 was clearly detected regardless of whether 
the culture was grown with or without apramycin, supporting the notion that the pFLAG vectors are kept stably 
integrated in the genome even without antibiotic selection. However, protein production was slightly lower in the 
absence of apramycin.
Generation of deletion mutants with the pKO vectors. The process of generating unmarked gene 
deletions with suicide plasmids is well established, but has some drawbacks: first, the genetic loci upstream and 
downstream of the target gene must be combined into one suicide vector over several cloning steps; second, the 
first recombination step is inefficient and requires large amounts of suicide vector for electroporation to obtain 
a few clones; and third, the second recombination step often yields false positive clones due to mutations in the 
counterselection gene. To address these issues we cloned the pKO vectors series (Fig. 5A), which offers the fol-
lowing three advantages: first, the flanking regions are cloned in one single cloning step into entry vector pINIT 
and are then transferred to any of the pKO destination vectors as described in Fig. 1C, which allows to test the 
three commonly used antibiotic selection markers conferring resistance towards hygromycin, kanamycin and 
apramycin with minimal effort; second, pKO vectors are relatively small (between 5.7 to 6.2 kb) and have a high 
copy number in E. coli, facilitating the production of large amounts of these vectors for electroporation; third, 
pKO vectors harbor the two counterselection genes sacB and galK, allowing for a tight counterselection29. To 
Vector Description Purpose
Antibiotic 
variants
Addgene 
ID
pMINTC3GH
Integrative vector for expression in mycobacteria based on the 
tet promoter. Contains a C-terminal 3 C cleavage site and a GPF-
fusion with a His10-tag.
Protein production and 
purification
Kan
Apr
Hyg
110076
110078
110077
pMINTC3H Analogous to pMINTC3GH but with a C-terminal 3 C cleavage site and His10 tag. Is devoid of GFP.
Protein production and 
purification Kan 110075
pMINTNH3 Analogous to pMINTC3GH but with an N-terminal His10 tag and 3 C cleavage site. Is devoid of GFP.
Protein production and 
purification Kan 110074
pMEXC3GH Analogous to pMINTC3GH, but containing oriM for episomal replication in mycobacteria.
Protein production and 
purification
Kan
Apr
Hyg
110081
110083
110082
pMEXC3H Analogous to pMINTC3H, but containing oriM for episomal replication in mycobacteria.
Protein production and 
purification Kan 110080
pMEXNH3 Analogous to pMINTNH3, but containing oriM for episomal replication in mycobacteria.
Protein production and 
purification Kan 110079
pACEC3GH
Replicative, acetamide-based expression vector containing a 
C-terminal 3 C cleavage site and a GPF-fusion with a His10-tag. 
Suitable for high-level expression levels amenable for large scale 
purification of proteins.
Protein production and 
purification
Hyg
Apr
110084
110085
pKO Suicide vector for generation of gene deletions in mycobacteria. Contains the two genes sacB and galK for negative selection. Gene deletion
Kan
Apr
Hyg
110086
110088
110087
pKO∆galK Analogous to pKO but without the negative selection gene galK. Gene deletion
Kan
Apr
Hyg
110089
110091
110090
pKO∆sacB Analogous to pKO but without the negative selection gene sacB. Gene deletion Kan 110092
pCOND Suicide vector based on the TetR/Pip OFF system. Conditional knockdown AprHyg
110094
110093
pFLAG_attP
Vector for low-level constitutive expression in mycobacteria 
from the tet promoter. Lacks the tet repressor. Contains attP for 
chromosomal integration. Lacks the integrase and thus remains 
stably integrated in the absence of antibiotic selection. Contains 
a C-terminal 3xFLAG to allow detection of expression levels by 
Western blotting.
Gene complementation Apr 110095
pMA_Int
E. coli replicative vector which contains the mycophage integrase 
gene required for the attP/attB integration. Is co-transformed 
in trans together with pFLAG_attP, but cannot replicate in 
mycobacteria, and is thus lost shortly after electroporation.
Gene complementation Amp 110096
pFLAG_OriM Analogous to pFLAG_attP, but containing oriM instead of attP, thus being a replicative vector. Gene complementation Hyg 110097
Table 1. List of mycobacterial destination vectors.
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Figure 3. Mycobacterial destination vector series for protein production and purification. (A) Schematic 
overview of the inducible expression vectors, ordered by expression strength. Relevant features are 
schematically depicted for each vector type. The three tagging variants are shown schematically. (B) Expression 
of a designed ankyrin repeat protein (DARPin) in integrative pMINTC3GH and replicative pMEXC3GH at 
varying ATc concentrations. The left panel shows expression levels detected by in gel GFP fluorescence of cell 
lysates separated by SDS-PAGE. The band between 35 and 40 kDa corresponds to the DARPin-GFP fusion 
protein. The right panel shows the quantification of DARPin-GFP fluorescence intensities. (C) Expression tests 
of the heterodimeric ABC transporters MSMEG_0017/18, MSMEG_5008/09, MSMEG_5659/60 and the MFS 
transporter Rv1258 cloned as GFP fusion proteins in expression vectors pMINTC3GH and pMEXC3GH. Total 
cell lysates were separated by SDS-PAGE and protein production was visualized by in gel fluorescence. Detected 
transporter-GFP fusion proteins are marked with arrows. Leaky expression was assessed using the pMEXC3GH 
constructs in the absence of inducer (n.i. stands for “not induced”). Supernatant of wildtype M. smegmatis 
was loaded as a negative control to assess background fluorescence (“neg”). (D) Side-by-side comparison of 
production levels of the MFS transporter Rv1410 and the heterodimeric ABC transporter MSMEG_6553/54 
expressed in pMINTC3GH, pMEXC3GH and pACEC3GH. The left panel shows the in gel fluorescence of 
total cell lysates separated by SDS-PAGE. Bands corresponding to the expected size of the transporter-GFP 
fusion protein are marked with an arrow. The right panel shows the quantification of protein production. 
(E) Schematic overview of preparative purification of tag-less Rv1410 and MSMEG_6553/54 expressed in 
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test the counterselection strength of the pKO vectors, we introduced the attP site instead of flanking regions. 
The pKO_attP vectors were then stably introduced into M. smegmatis by co-electroporation in trans with the L5 
bacteriophage integrase present on the suicide vector pMA_Int. Stable integrants were first selected on agar plates 
containing the appropriate antibiotic (hygromycin, kanamycin or apramycin) and confirmed by colony PCR. As 
a control, either the galK or the sacB gene was deleted on the pKO vector carrying the kanamycin marker (pKO_
KanΔgalK, pKO_KanΔsacB) and was integrated into the genome of M. smegmatis, accordingly. Subsequently, the 
integrants were grown to stationary phase, and streaked onto plates containing a gradient of the counterselection 
sugars sucrose and 2-deoxy-galactose. As expected, counterselection using both markers resulted in a more effi-
cient killing of M. smegmatis than integrants harboring only sacB or galK (Fig. 5B). In parallel tests using the same 
flanking regions in pKO vectors carrying the hygromycin, kanamycin or apramycin resistance markers, respec-
tively, we found that pKO_Apr had the best performance in M. smegmatis. For M. marinum, only pKO_Hyg was 
tested. In M. smegmatis, hygromycin performed rather poorly, because there was substantial background growth 
on 7H10 plates, and kanamycin led to fewer positive clones compared to apramycin. However, it is expected that 
this set of antibiotic markers likely performs differently in other mycobacterial species, and therefore, we advise 
to test the entire pKO series to identify the optimal selection marker. After rigorously assessing positive selection 
and counterselection, we used the pKO_Apr vectors to generate 20 unmarked gene deletions in M. smegmatis 
encoding potential multidrug efflux pumps. The transporters belong to four protein superfamilies, the major 
facilitator superfamily (MFS), the small multidrug resistance (SMR), the multidrug and toxin extrusion (MATE) 
and the ATP binding cassette (ABC) transporters (Table 2). Gene deletions were verified by PCR amplifying the 
deleted region (Fig. 5C). These unmarked gene deletion mutants were tested for increased antibiotic susceptibility 
against twelve antibiotics and the drug efflux dye ethidium. This extensive analysis revealed an 8-fold increased 
ethidium susceptibility for cells containing a deletion in msmeg_6225 (encoding the previously described MFS 
drug transporter LfrA30) and a 2-fold increased susceptibility for cells devoid of msmeg_3705, encoding an MFS 
transporter previously described as drug efflux pump31. Remarkably, our analysis did not reveal increased antibi-
otic susceptibilities for any other gene deletion. This finding was surprising, because some bacteria contain dom-
inant drug efflux pumps such as the AcrAB-TolC system of E. coli or the heterodimeric ABC exporter LmrCD 
of L. lactis, whose chromosomal deletion leads to a pronounced increase of drug susceptibility32,33. Our finding 
indicates that M. smegmatis either contains a multitude of redundant drug efflux pumps, which compensate for 
each other in case one is deleted, or drug efflux does not play a dominant role for antibiotic sensitivity in this 
organism. To test the applicability of the pKO vector series for other mycobacterial species, the three genes sapM 
(mmar_1216), icL (mmar_0792) and phoP (mmar_4942) were deleted in M. marinum. To our knowledge, so far 
only two publications describe the successful generation of defined gene deletions mutants in M. marinum34,35, 
but both are based on phage transduction and not suicide vectors, and thus require resolvase genes to render the 
deletions unmarked36. We used the vector pKO_Hyg to generate unmarked gene deletions of these genes, and 
gene deletions were confirmed by PCR and Sanger sequencing (Fig. 5C).
Generation of conditional knockdowns. If an essential gene is targeted, deletion mutants cannot be 
obtained. Therefore, conditional knockdown mutants are generated to study the function of essential genes. 
Knockdowns can be generated either at the transcriptional level by using for example the tetracycline repres-
sor (TetR)-controlled expression system11 or at the protein level by tagging an essential protein for proteolytic 
degradation6. Here, we opted for the TetR/Pip OFF repressible promoter system, because of its strong and tight 
gene activation and repression5. In this system, the essential gene is placed under the control of the pristamycin 
promoter (Pptr) which is tightly repressed by the pristamycin repressor (Pip). Expression of the pip gene in turn 
is under the control of the tetracycline repressor TetR, which is constitutively produced. In the absence of ATc, 
production of Pip is repressed and the essential gene under the control of Pptr is expressed. In the presence of ATc, 
Pip is produced, represses Pptr and leads to a depletion of the essential gene product5 (Fig. 6). We adapted this sys-
tem to our FX cloning platform and constructed pCOND. This suicide vector carries Pptr followed by SapI sites to 
clone the first 500–600 bp of an essential gene of interest under the control of Pptr. We constructed pCOND con-
taining either a hygromycin or an apramycin resistance marker with an E. coli origin of replication for cloning and 
plasmid propagation (Fig. 6). For a project on siderophore transporters, we aimed to engineer an M. smegmatis 
strain, which produces high amounts of the soluble siderophore carboxymycobactin37. A strain containing a gene 
knockout of the iron regulator ideR was reported to exhibit de-repressed siderophore biosynthesis38. However, 
our own attempts to delete ideR were not successful. Therefore, we used pCOND to generate a conditional knock-
down of ideR in M. smegmatis. To this end, the first 513 bp of the ideR gene were cloned by FX cloning via pINIT 
into pCOND_Apr. The construct was then integrated into the genome of M. smegmatis by homologous recombi-
nation, thereby replacing the native promoter of ideR by Pptr. Subsequently, the plasmid pFRA61.1, which carries 
TetR and the gene encoding the Pip repressor under a promoter repressed by TetR as described previously5, was 
integrated via attP/attB recombination into this M. smegmatis strain. The resulting conditional knockdown strain 
was grown in minimal medium in the presence of increasing ATc concentrations, and siderophore secretion into 
the medium was measured with the chrome azurol S (CAS) assay39. In this assay, empty siderophore captures Fe3+ 
from a colored dye-iron complex, leading to an absorption decrease as a measure of siderophore production. As 
pACEC3GH for structural biology purposes. (F) Size exclusion chromatography (SEC) profiles of purified 
Rv1410 and MSMEG_6553/54. Elution peaks corresponding to Rv1410 and MSMEG_6553/54 are marked by a 
yellow arrow. (G) SDS-PAGE analysis and Coomassie staining of transporters as eluting from SEC shown in (F). 
Of note, the two bands observed for MSMEG_6553/54 correspond to MSMEG_6553 (upper band at around 
100 kDa) and MSMEG_6554 (lower band at around 65 kDa).
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expected, the conditional ideR strain showed increased siderophore production upon induction with increasing 
ATc concentrations compared to the wildtype strain (Fig. 6C).
Discussion
Mechanistic research on mycobacteria critically depends on genetic tools to generate deletion mutants and to 
express wildtype and mutated genes under the control of inducible promoters. In the past three decades, a pleth-
ora of vectors to genetically manipulate mycobacteria has therefore been created and successfully used. In par-
ticular for biochemical and structural studies on membrane proteins, efficient tools for protein production in and 
purification from the mycobacterial workhorse species M. smegmatis are highly relevant. However, standardized 
cloning and expression systems for efficient construct screening as they are available for other commonly used 
expression hosts such as E. coli27 and Saccharomyces cerevisiae40 did not exist for M. smegmatis. In this work, we 
adapted a broad range of mycobacterial vectors to be used with the efficient and cost-effective FX cloning sys-
tem41. The protocol starts with the cloning of ORFs or homology regions into an entry vector following the same 
robust cloning protocol using just one single type IIS restriction enzyme, SapI (or its isoschizomers BspQI and 
LguI). Due to the high GC content, mycobacterial genes are notoriously difficult to amplify by PCR. Once the 
genes or flanking regions of interest are safely introduced in the entry vector and their sequence confirmed, they 
can be transferred by fragment exchange into any of the mycobacterial FX vectors and do not need to be ampli-
fied again by PCR to introduce new restriction sites compatible with the destination vector. Thereby, FX cloning 
removes a major source of errors and avoids tedious troubleshooting.
At the heart of our platform are three vector series for (membrane) protein overproduction in M. smegmatis, 
ranging from low level gene expression (pMINT vectors), medium level expression (pMEX vectors) to high level 
expression (pACE) amenable for preparative scale protein purification. Various tagging variants exist for this 
vector series, introducing His10-tags for Ni2+-NTA purification either N- or C-terminally fused to the cloned 
ORF, which can be cleaved by the highly efficient 3 C protease to obtain untagged protein for structural biology 
purposes. As an option, the ORF can be expressed fused to GFP for high-throughput expression screening by 
in gel fluorescence27. Last but not least, the expression vector series exists for three commonly used selection 
markers conferring hygromycin, kanamycin and apramycin resistance, respectively. For M. smegmatis, apramycin 
emerged as our preferred antibiotic, because it is inexpensive, highly selective and does not affect bacterial growth 
rate to the extent as kanamycin.
The pFLAG vector was found to be ideally suited for gene deletion complementation in a variety of projects 
involving transporter knockouts (unpublished results). In pFLAG, the cloned gene is constitutively expressed 
from the medium strength tetracycline promoter, and consequently, no inducer is required during a complemen-
tation experiment. Although constitutive expression does not allow for tuning expression levels by optimizing 
the inducer concentration, we so far did not experience problems in our own complementation attempts. Of note, 
vectors of the pMINT series are an attractive alternative for complementation studies, because they are integrative 
vectors akin to pFLAG, but gene expression is under the control of the inducible TetR repressor10. Importantly, 
pFLAG_attP lacks the integrase gene, which permits its stable integration into the genome by transiently provid-
ing the integrase on a suicide vector in trans28. This allows for complementation experiments in the absence of 
antibiotics, thereby alleviating side effects attributed to cellular stress induced by antibiotics. Although expression 
levels obtained with pFLAG are rather low, protein production could be readily detected using the highly sensitive 
anti-FLAG antibody, which recognizes the C-terminally fused 3xFLAG-tag.
The pKO vector series allows for efficient generation of unmarked gene deletions. The FX cloning method 
was adapted to clone the flanking homology regions in a single cloning step using SapI as the only restriction 
enzyme. A similar approach to clone flanking regions was recently chosen using the type IIP restriction enzyme 
Van91I9. The size of the pKO vectors was kept minimal, and they replicate as high copy vectors in E. coli, facili-
tating the preparation of highly concentrated plasmid stocks for efficient electroporation into mycobacteria. The 
Figure 4. Mycobacterial complementation vector pFLAG for constitutive low-level expression. (A) Schematic 
overview of the pFLAG vector depicting relevant features. (B) Detection of Rv1410-3xFLAG produced from 
integrative vector pFLAG_attP in the presence or absence of apramycin. Total cell lysate supernatants were 
separated as a two-fold dilution series by SDS-PAGE and Rv1410-3xFLAG was detected by Western blotting 
using an anti-FLAG antibody. The uncropped Western blot image is shown in Supplementary Fig. S1.
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two marker genes sacB and galK ensure tight counterselection and minimize the number of false positive clones 
in the second recombination step. The pKO vectors come with the three most commonly used selection markers 
conferring hygromycin, kanamycin and apramycin resistance. Thus, the most appropriate antibiotic can be cho-
sen depending on the mycobacterial species.
Finally, we also generated the pCOND series containing apramycin or hygromycin resistance markers, which 
was successfully used to generate a conditional knockdown of the iron regulator protein IdeR in M. smegmatis to 
increase the production and secretion of the siderophore carboxymycobactin37.
We successfully validated these mycobacterial FX vectors in our own and other selected labs for membrane 
protein production and purification. Further, we generated a large set of unmarked gene deletions and carried out 
complementation studies. To our knowledge, this is the first reported uniform and consistent cloning platform 
spanning protein production and knockout generation in mycobacteria. This resource is available on Addgene 
(www.addgene.org) for the growing community of biochemists and structural biologists aiming at the molecular 
investigation of mycobacterial (membrane) proteins. We anticipate that this vector series will facilitate research 
in other labs as it permits to screen multiple expression and gene deletion constructs in parallel, all based on the 
cost-effective open-access FX cloning system with its straightforward primer design and high cloning efficiencies.
Figure 5. Mycobacterial destination vector series pKO for the generation of unmarked gene deletions.  
(A) Schematic overview of pKO vectors depicting relevant features. (B) Counterselection test of pKO vectors.  
M. smegmatis harboring different pKO versions stably integrated via attP/attB recombination was streaked on 
gradient plates containing an increasing amount (from left to right) of sugars for counterselection. Wildtype 
M. smegmatis was streaked as a control. (C) Generation of unmarked gene deletions of the heterodimeric ABC 
transporters msmeg_5008/09 and msmeg_5659/60 in M. smegmatis as well as sapM, icL and phoP in M. marinum. 
Shown are agarose gels of PCR products amplified from genomic DNA. For M. smegmatis (left), PCR products 
amplified from two gene deletion clones (1 and 2, expected size of ~3 kB), the strain containing the integrated 
suicide plasmid as obtained after the first recombination step (i, expected sizes of ~3 kB and ~6 kB), and wildtype 
controls (wt, expected size of ~6 kB) are shown. In strains containing the integrated suicide plasmid, the 3 kB 
fragment is amplified more efficiently than the 6 kB fragment. For M. marinum (right), gene deletions and wildtype 
controls are shown. The expected sizes of the PCR products for mutant/wildtype are as follows: For sapM ~2.5 kB/ 
~3 kB, for icL ~2.4 kB/ ~3.2 kB and for phoP ~1.8 kB/ ~2.5 kB.
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Materials and Methods
Strains, media and antibiotics concentrations. The E. coli XL1-Blue strain was used for cloning the 
mycobacterial FX vectors. Luria Broth (LB) was used for liquid cultures, and Luria Broth Agar (LB Agar) for 
plates. Antibiotics were used in the following concentrations for E. coli: ampicillin (Amp) 100 µg/ml, kanamycin 
(Kan) 50 µg/ml, chloramphenicol (Cm) 25 µg/ml, apramycin (Apr) 50 µg/ml and hygromycin (Hyg) 100 µg/ml. 
M. smegmatis mc2 155 was used in all experiments involving M. smegmatis. 7H9 with OADC supplement was 
used for liquid cultures, and 7H10 with OADC supplement was used for plates. Antibiotics were used in the 
following concentrations for M. smegmatis: kanamycin 25 µg/ml, apramycin 25 µg/ml and hygromycin 50 µg/ml. 
If not stated otherwise, cells were incubated and grown at 37 °C. M. marinum M (ATCC BAA-535) was used for 
gene deletion generation in M. marinum and grown at 30 °C.
Construction of the tetracycline-inducible vectors pMINT and pMEX. The backbone of the 
TetR-based expression vector pGMCKq1-10M1-sspBmyc6 (Addgene) was amplified with the 5′-phosphorylated 
primers pGMCK Fw and pGMCK Rv, yielding a linear PCR fragment (for primer sequences see Table S1). 
Another linear fragment was generated by PCR using the FX vector pBXC3GH24 as a template with the primers 
pBXC3GH Fw and pBXC3GH Rv. Both linear PCR products were ligated by blunt ligation. After transforma-
tion, clones carrying the desired ligation construct resulting in the vector pMINTC3GH were selected based on 
restriction digest analysis. The vector pMINTC3H was generated by amplifying pMINTC3GH with the primers 
pMINTC3H Fw and pMINTC3H Rv. The linear PCR fragment was self-ligated by blunt-end ligation, yielding 
the vector pMINTC3H. The vector pMINTNH3 was constructed analogously to the vector pMINTC3GH, by 
blunt-end ligation of the backbone of pGMCKq1-10M1-sspBmyc with the linear fragment amplified from the 
FX vector pBXNH3 using the primers pBXNH3 Fw and pBXNH3 Rv. To generate the respective pMEX vectors 
(pMEXC3GH, pMEXC3H and pMEXNH3) the oriM was amplified from the vector pMYC by PCR using the 
primers pMYC_OriM Fw and pMYC_OriM Rv. Vector pMYC (Addgene plasmid #42192) is a pSD26 deriv-
ative12. The three pMINT vectors were amplified by using the primers pMINT_OriM Fw and pMINT_OriM 
Rv. PCR fragments of the three vector backbones and oriM were digested by BbsI and XbaI and ligated accord-
ingly to form the vectors pMEXC3GH, pMEXC3H and pMEXNH3. Being based on backbone of vector pGM-
CKq1-10M1-sspBmyc, the initial set of pMINT and pMEX constructs harbors a kanamycin resistance cassette. 
To produce the respective pMINT and pMEX vectors harboring an apramycin or a hygromycin resistance gene, 
the pMINT and pMEX backbones were amplified using the 5′-phosphorylated primers pMINT/MEX_bb Fw 
and pMINT/MEX_bb Rv. The genes encoding the apramycin and hygromycin resistance were amplified from the 
vectors pSET15242 and pMYC, respectively, using the primers pSET_apr Fw and pSET_apr Rv, and pMYC_hyg 
Fw and pMYC_hyg Rv. The linear PCR fragment forming the pMINT and pMEX backbone was then obtained by 
blunt-end ligation to the respective PCR fragments containing the apramycin and hygromycin resistance genes to 
yield the pMINT and pMEX vectors with apramycin and hygromycin resistance markers.
Construction of the acetamidase based expression vector pACE. The backbone of the 
acetamide-inducible expression vector pMYC was amplified using the 5′-phosphorylated primers pMYC_bb 
Fw and pMYC_bb Rv. The same PCR fragment amplified from the FX vector pBXC3GH mentioned above was 
ligated via blunt ends to the amplified pMYC backbone. After transformation clones carrying the desired ligation 
construct resulting in pACE_Hyg were selected by restriction digest analysis. To make the pACEC3GH vector 
ABC MATE MFS SMR
wild 
type
ΔMS 
MEG_ 
0017/ 
0018
ΔMS 
MEG_ 
1502/ 
1504
ΔMS 
MEG_ 
1642
ΔMS 
MEG_ 
4380
ΔMS 
MEG_ 
5008/ 
5009
ΔMS 
MEG_ 
5075/ 
5076
ΔMS 
MEG_ 
5659/ 
5660
ΔMS 
MEG_ 
6509/ 
6510
ΔMS 
MEG_ 
2631
ΔMS 
MEG_ 
3563
ΔMS 
MEG_ 
3705
ΔMS 
MEG_ 
5046
ΔMS 
MEG_ 
5187
ΔMS 
MEG_ 
5670
ΔMS 
MEG_ 
6225  
(LfrA)
ΔMS 
MEG_ 
6390
ΔMS 
MEG_ 
3670
ΔMS 
MEG_ 
3672
ΔMS 
MEG_ 
3815
ΔMS 
MEG_ 
6221
Isoniazid 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200 200
Rifampicin 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
Ethambutol >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10 >10
Streptomycin 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25
Kanamycin 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Ofloxacin 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6
Ciprofloxacin 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6
Ampicillin 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125 125
Chloramphenicol 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32
Tetracycline 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2
Vancomycin 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Novobiocin 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16
Ethidium 6 6 6 6 6 6 6 6 6 6 3 6 6 6 0.75 6 6 6 6 6 6
Table 2. MIC values (µg/ml) of multidrug transporter gene deletion mutants compared to wildtype M. 
smegmatis. The transporters are sorted according to transporter families. MIC determinations were carried 
out as technical duplicates. In the rare event that the two values differed, the higher of the two MIC values was 
reported.
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fully compatible with the FX protocol, the internal SapI restriction site located on the amiS gene of the aceta-
midase operon was altered using the QuikChange primers pACE_sapI Fw and pACE_sapI Rv. To generate the 
vector pACE_Apr, pACE_Hyg was amplified with the phosphorylated primers pACE_Apr Fw and pACE_Apr 
Rv and ligated via blunt ends with the PCR product amplified with the primers pSET_apr Fw and pSET_apr Rv 
from pSET152.
Construction of complementation vector pFLAG. Three different vectors were used to construct the 
pFLAG_attP vector: pMINT∆TetR, pBXCF3GH and pCOND with apramycin resistance (see below). The vector 
pMINT∆TetR was obtained by removing the Tet repressor (TetR) of pMINTC3GH using the 5′-phosphorylated 
primers pMINT∆TetR Fw and pMINT∆TetR Rv, followed by self-ligation of the resulting PCR product. The 
vector pBXCF3GH was generated by amplifying the pBXC3GH vector with the 5′-phosphorylated primer pair 
pBXCF3GH Fw and pBXCF3GH Rv. The linear PCR product was self-ligated to obtain pBXCF3GH, which is a 
pBXC3GH vector containing a 3xFLAG tag sequence upstream of the 3 C cleavage site. To construct pFLAG_attP, 
three linear PCR fragments were amplified: the first fragment from pMINT∆TetR with primers pMINT∆TetR_
bb Fw and pMINT∆TetR_bb Rv, the second fragment from pBXCF3GH with the primers pBXCF3GH_bb Fw 
and pBXCF3GH_bb Rv, and the third fragment from pCOND_Apr (see below) with the primers pCOND_APR_
bb Fw and pCOND_APR_bb Rv. The first two fragments were used as megaprimers for an overlap extension PCR 
using primers pMINT∆TetR_bb Fw and pBXC3F3GH_bb Rv. The resulting product was cloned by blunt-end 
ligation with the third fragment to generate the vector pFLAG_attP. Correct clones were identified by restriction 
analysis. pFLAG_attP lacks the phage integrase gene for specific recombination via the attP/attB site. Therefore, 
we constructed the vector pMA_SapI, which is a pMA vector (Thermo Fisher Scientific) adapted to FX cloning 
via two SapI sites. To this end, we amplified pMA with the 5′-phosphorylated primers pMA_FX Fw and pMA_FX 
Rv and blunt-end ligated the PCR product to generate the vector pMA_SapI. Subsequently, we amplified the 
integrase gene from pMINTC3GH with the primers Int Fw and Int Rv and cloned it into pMA_SapI to generate 
the vector pMA_Int, which was used for all subsequent electroporations where the integrase needs to be delivered 
in trans.
Figure 6. Mycobacterial destination vectors pCOND for generation of conditional knockdowns. (A) Schematic 
overview of pCOND vectors. (B) The native promoter of an ORF is first replaced by Pptr using homologous 
recombination. The Pip protein repressing Pptr is encoded on the pFRA61.1 vector under the control of the 
inducible tetracycline promoter system. (C) Left, PCR to test integration (i) of the pCOND vector into M. 
smegmatis for two clones of ideR conditional knockdowns, and PCR to test for the presence of the pip promotor 
(p). Right, CAS assay to monitor the biosynthesis and secretion of the siderophores for the ideR conditional 
knockdown strain grown at different concentrations of ATc. Higher ATc concentrations lead to increased 
siderophore production, resulting in lower A/Aref values in the CAS assay.
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Construction of the pKO vector series. The pKO vector containing the kanamycin resistance marker 
was constructed in two steps. First, two linear PCR fragments were amplified from the vectors pMA_SapI and 
pDB7729 using 5′-phosphorylated primer pairs pMA_SapI Fw and pMA_SapI Rv, and pDB77 Fw and pDB77 
Rv, respectively, followed by the blunt-end ligation of the resulting PCR products. The internal SapI site on 
pMA_DB77 was removed using the QuikChange primers pMA_DB77 Fw and Rv, yielding the new vector 
pKO∆sacB. In a second step, the backbone of vector pKO∆sacB was amplified with the primer pair pKO∆sacB 
Fw/pKO∆sacB Rv. The sacB gene was amplified from the FX vector pINIT24 with the primers pINIT_sacB Fw and 
pINIT_sacB Rv. Both fragments were digested with BbsI and XbaI and then ligated to form the vector pKO_Kan, 
harboring the counterselection genes galK and sacB along with a kanamycin resistance gene. Additionally, pKO 
vectors with hygromycin and apramycin resistance (pKO_Hyg and pKO_Apr) were generated by cloning the 
hygromycin and apramycin genes (as used to construct the pMINT series) via XbaI and NcoI restriction sites. 
Finally, the pKO∆galK vectors containing either kanamycin, hygromycin or apramycin resistance markers were 
generated by BamHI digest to excise the galK gene followed by self-ligation.
Construction of the pCOND vectors. The vector pTE (Addgene plasmid #20320) was amplified with the 
5′-phosphoraylated primers pTE_bb Fw and pTE_bb Rv, and the PCR product was blunt-end ligated to the same 
PCR product containing the apramycin cassette described in the construction of the pMINT and pMEX vectors, 
resulting in the vector pTE_Apr. Both pTE and pTE_Apr were used as a backbone for the construction of the 
pCOND vector. The backbone of the pTE vectors was amplified using the forward primer pTE Fw and pTE Rv, 
both containing a BamHI overhang. The pristamycin promoter (Pptr) was amplified by PCR from vector pFRA505 
using the primer pair pFRA50 Fw and pFRA50 Rv, both containing a BamHI overhang. Both PCR products were 
then digested with BamHI and ligated to form pCOND (with apramycin and hygromycin resistance, depending 
on the pTE backbone).
Cloning of ORFs for protein production. ORFs encoding genes of interest were PCR amplified using 
Q5 DNA polymerase (NEB) from genomic DNA for M. smegmatis and M. marinum, and from the H37Rv bac-
mid library43 for M. tuberculosis. Amplification was performed with FX-compatible primers designed with the 
FX-primer tool (www.fxcloning.org). The amplicons were cloned into the pINIT vector according to the FX 
protocol and sequenced. In brief, about 200 to 500 ng PCR product was mixed with 50 ng pINIT vector, 1 × NEB 
CutSmart buffer, 1 µl BspQI (10 units) (NEB, isochizomer of SapI) and the volume was adjusted to 10 µl with 
water. The reaction was then incubated for 1 hour at 50 °C for BspQI DNA digestion, followed by 20 minutes at 
80 °C for heat inactivation of BspQI. Afterwards, to the same reaction 1.25 µl 10 mM ATP and 1.25 µl T4 ligase 
(5 Weiss Units) (NEB) was added, and the reaction was incubated 1 hour at 25 °C for ligation. Subsequently, the 
ligase was heat inactivated 20 minutes at 65 °C, and 10 µl of the reaction was transformed into 50 µl chemically 
competent E. coli XL1-Blue cells. All ORFs carry an additional AGT codon at the 5′ end introducing a serine 
residue at the N-terminus, and an additional GCA codon at the 3′ end translating as C-terminal alanine residue. 
Subcloning into expression vectors was again performed according to the FX protocol as described41. In brief, 
about 500 ng pINIT vector (containing ORF) was mixed with 50 ng destination expression vector. The subsequent 
steps were identical to the cloning of ORFs described before, i.e. first digestion with BspQI followed by ligation 
with T4 ligase, and with subsequent transformation into XL1-Blue cells. Approximately 0.5–1.0 µg of the expres-
sion vector was electroporated into M. smegmatis, recovered for 3.5 hours at 37 °C in 7H9 and plated on 7H10 
plates with suitable antibiotics. Clones carrying the expression vectors were confirmed by colony PCR.
Small-scale protein production for in gel GFP analysis. 10 ml 7H9 cultures supplemented with the 
suitable antibiotics were inoculated 1:25 with 7H9 precultures of M. smegmatis carrying pACE, pMEX or pMINT 
vectors and grown at 37 °C while shaking, until the cultures reached an OD600 of around 0.6. Cells were then 
induced with 100 ng/ml ATc (pMINT and pMEX) or 0.4% (w/v) acetamide (pACE) and grown overnight at 
37 °C. 4 ml of cells were harvested in 2 ml tubes and resuspended in 350 μl 20 mM Tris/HCl pH 8, 200 mM NaCl. 
A spatula tip of acid-washed glass beads ≤106 µm (Sigma) was added and the cells were subsequently lysed with a 
FastPrep-24 Classic cell lysis machine (MP Biomedicals) for 3 cycles of 60 seconds with 6 m/s. The lysate was spun 
15 minutes at 14’000 rpm at 4 °C with a F-45-30-15 rotor (Eppendorf) to pellet glass beads and cell debris. 40 μl of 
supernatant were mixed with 10 μl of 5 × SDS loading dye (120 mM TRIS pH 6.8, 50% glycerol, 100 mM DTT, 2% 
SDS (w/v), 0.1% bromophenol blue (w/v)), of which 10 µl were loaded on a 10% SDS-PAGE gel. The GFP-fusions 
were detected by in gel fluorescence with an ImageQuant LAS 4000 instrument (GE Healthcare). The exposure 
time was adjusted according to the intensity of the signal, and varied between 10 and 60 seconds.
Large-scale protein production and purification for size-exclusion chromatography analysis. 
For large-scale protein production with M. smegmatis, 4.5 liter (MSMEG_6553/6554) or 9 liter (Rv1410) cultures 
of 7H9 supplemented with hygromycin were inoculated 1:25 with dense M. smegmatis precultures carrying the 
respective pACE constructs. Cells were grown at 37 °C until they reached an OD600 of approximately 0.6, and 
then were induced with 0.4% (w/v) acetamide. Protein production was induced overnight at 37 °C, and cells were 
harvested. All further steps were performed at 4 °C or on ice. Cells were resuspended in 20 mM Tris/HCl pH 8, 
200 mM NaCl, and a spatula tip of DNase I was added and homogenized by sonication. Cells were lysed with a 
microfluidizer M-110P (Microfluidics) with 3 passes at 25 KPa. The lysate was first centrifuged for 30 minutes 
at 8’000 g to remove cell debris. The supernatant was then ultracentrifuged at 170’000 g for 2 hours to pellet the 
membrane vesicles. The vesicles were resuspended in 20 mM Tris/HCl pH 7.5, 150 mM NaCl (TBS) containing 
10% glycerol, flash-frozen with liquid nitrogen and stored at −80 °C until further use. Membrane proteins were 
extracted and purified from the membranes essentially as described25. Briefly, membrane proteins were extracted 
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with 1% (w/v) n-dodecyl-β-D-maltopyranoside (β-DDM) for 2 h, followed by ultracentrifugation at 170’000 g 
for 30 minutes. The supernatant containing extracted membrane proteins was loaded onto a Ni2+NTA Superflow 
gravity flow column (Qiagen). The column was washed with 30 column volumes with 50 mM imidazole pH 7.5, 
150 mM NaCl and 10% glycerol, and the proteins were subsequently eluted with 5 column volumes of 200 mM 
imidazole pH 7.5, 150 mM NaCl and 10% glycerol. Eluted proteins were desalted in 20 mM Tris/HCl pH 7.5, 
150 mM NaCl (TBS) using a PD-10 column (GE Healthcare), and the GFP-His10 tag was cleaved overnight by 
incubation with homemade 3C protease. Cleaved proteins were purified by reverse Ni2+NTA. Cleaved protein 
was washed from the column with 5 column volumes of 20 mM Tris/HCl pH 7.5, 150 mM NaCl (TBS). The 
proteins were concentrated using Amicon Ultra concentrators from Merck Millipore (30 kDa cutoff for Rv1410 
and 100 kDa cutoff for MSMEG_6553/54) and loaded on a Superdex 200 Increase 10/300 GL (GE Healtcare) 
size-exclusion chromatography column.
Production of pFLAG fusion proteins and Western blotting. M. smegmatis carrying chromosomally 
integrated pFLAG_attP_Rv1410 was grown in 7H9 medium with or without apramycin. 1 ml of a stationary phase 
culture were pelleted and resuspended in 500 µl 20 mM Tris/HCl pH 8, 200 mM NaCl. Cells were then lysed with 
a FastPrep-24 machine (for details see above), and a 2-fold dilution series of the supernatants was separated on a 
SDS-PAGE gel. Separated proteins were transferred to a membrane (Immobilon-PSQ, Merck). For this purpose, 
the gel and membrane were soaked in transfer buffer (2.9 g glycine, 5.8 g Tris, 0.1% SDS (w/v) and 20% methanol 
(v/v) in 1 liter), and the transfer was performed with a Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell 
(BIO-RAD) for 1 h at 12 V. The membrane was blocked in PBS buffer containing 5% (w/v) milk powder and 
0.05% (v/v) Tween20 for 1 h at RT, incubated in blocking buffer with anti-FLAG antibody (Sigma, F3165) diluted 
1:10’000 (v/v) for 1 h at RT while rotating and then washed 3x with washing buffer (PBS containing 0.05% (v/v) 
Tween20). An incubation of 1 h at RT while shaking in 30 ml of blocking buffer and α-mouse-HRP antibody 
(Sigma, A5278) diluted 1:30’000 (v/v) ensued. The membrane was washed again 3x with washing buffer, and 
finally, the proteins were visualized by adding Immobilon Western Chemiluminescent HRP Substrate (Merck) 
and measuring chemiluminescence using ImageQuant LAS 4000 (GE Healthcare).
Testing the counterselection strength of pKO vectors. To test the counterselection strength of pKO 
vectors, M. smegmatis strains were generated with stably integrated pKO vectors via attP/attB site-specific recom-
bination. For this purpose, the attP site was cloned via FX-cloning into the pKO vectors and the vectors were elec-
troporated with the vector pMA_Int (see above) providing the integrase in trans28. Colonies of single clones were 
picked and inoculated in medium containing the respective antibiotic of the pKO vector, and the pKO integration 
site was checked by colony PCR. For assessing the counterselection strength, the strains were grown in liquid 
culture supplemented with the respective antibiotics to stationary phase (three nights). From this stationary phase 
culture 2 μl cells were streaked with a sterile loop onto gradient 7H10 plates devoid of antibiotics containing max-
imally 20% (w/v) sucrose and 0.2% (w/v) deoxy-galactose. The plates were incubated for three nights at 37 °C.
Generation of gene deletions in M. smegmatis and M. marinum with pKO vectors. For the gener-
ation of gene deletions, the upstream and downstream flanking region of the targeted locus, each having a length 
in the range of 1 to 1.5 kb, were amplified from genomic DNA. The forward primers to amplify the upstream 
flanks and the reverse primers to amplify the downstream flanks were standard FX primers designed according 
to the FX primer tool (www.fxcloning.org). For reverse primers of the upstream flanking region, primers of the 
form 5′-tatatatGCTCTTCaAGG[…]-3′ were used, and for forward primers of the downstream flanking regions, 
primers of the form 5′-atatatGCTCTTCtCCT[…]-3′ were used, where […] corresponds to the sequence which 
anneals on the genomic DNA. Amplified flanking regions were then cloned in one restriction and ligation reac-
tion into pINIT, sequenced, and then transferred by fragment exchange to the respective pKO vectors in E. coli. 
Approximately 1 µg of pKO vector was electroporated into 100 µl electrocompetent M. smegmatis or 400 µl electro-
competent M. marinum cells. Electrocompetent cells were prepared by established protocols44. Briefly, M. smegmatis 
or M. marinum cells were grown to approximately OD600 = 1, harvested and washed at least twice with 10% glyc-
erol and taken up in 1:100 (M. smegmatis) or 1:10 (M. marinum) of the culture volume. For M. smegmatis, the 
procedure was performed on ice with ice-cold 10% glycerol. For M. marinum the 10% glycerol solution was sup-
plemented with 0.05% (v/v) Tween 80 (Sigma) or Tyloxapol (Sigma) and preparation of the cells was performed 
at room temperature. For M. smegmatis the cells were recovered for 3.5 hours in 7H9 medium at 37 °C and then 
plated on 7H10 plates with the appropriate antibiotics. For M. marinum, the cells were recovered for 4 hours at 
30 °C and the plates incubated at 30 °C. Colonies were picked and grown in 7H9 supplemented again with anti-
biotics. For both, M. smegmatis and M. marinum, clones were checked for successful integration by PCR. Primer 
pairs were designed in such a way, that one primer would anneal on the genome and the other on the integrated 
plasmid and yield a PCR product of the correct size only upon integration of the plasmid. The single cross-over 
transformants were subsequently grown in 7H9 without antibiotics to allow second recombination events to 
occur. Approximately 2 µl of cells from these cultures were then plated on 7H10 plates containing the counterse-
lection substrates sucrose (20% w/v) and 2-deoxy-galactose (0.2% w/v). Clones were picked, grown in 7H9 and 
screened with colony PCR for gene deletions. Deletion mutants were in addition tested for antibiotic suscepti-
bility by growing the strains with and without antibiotic supplementation in 7H9 medium. Positive clones were 
confirmed by repeating the PCR reaction using isolated genomic DNA as template. The resulting PCR product 
was finally sequenced to confirm the deleted region in the genomic context. A list of all primers used for cloning 
of the flanking regions can be found in Supplementary Table 3.
MIC testing of M. smegmatis deletion mutants. M. smegmatis deletion mutants were grown for 3 
nights at 37 °C in 7H9 medium while shaking. These cultures were diluted 1:15 (v/v) in fresh 7H9 medium and 
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were grown again for 5 hours to obtain OD600 = 0.3 to 0.4. Subsequently, the culture was diluted 1:200 (v/v) to 
generate a working culture for an MIC test in a 96 well format, with 12 different concentrations of drugs per row 
present in a 2-fold dilution. For each MIC determination, two technical replicates were determined. Stock solu-
tions of the drugs were prepared in H2O (ampicillin, streptomycin, vancomycin, kanamycin, ethidium bromide, 
ethambutol, isoniazid), 2.5% (v/v) DMSO (tetracyclin, erythromycin, rifampicin, novobiocin, chloramphenicol, 
pyrazinamide) or 0.1 M HCl (ofloxacin, ciprofloxacin). To prepare each well of the 96 well plate, 5 µl of drug at the 
appropriate concentration was mixed with 95 µl 7H9 medium and subsequently inoculated with 100 µl working 
culture. Plates were sealed with adhesive plate seals (Thermo Scientific) and incubated for 48 hours at 37 °C. 30 μl 
of 0.01% (w/v) resazurin was added into each well and the plate was again closed with a plate sealer and incubated 
for 6 h at 37 °C. The fluorescent intensity of metabolized resazurin (converted into resorufin) was determined with 
a Synergy H1 plate reader (BioTEK) at an excitation wavelength of 530 nm and emission wavelength of 590 nm. 
In the case of isoniazid, MIC values were determined by OD600 measurement since isoniazid interfered with flu-
orescence detection of resorufin.
Generation and testing of the conditional knockout ideR in M. smegmatis with pCOND. The 
first 513 bp of the ideR gene encoding for MSMEG_2750 of M. smegmatis were amplified by PCR with the prim-
ers ideR Fw and ideR Rv (designed with www.fxcloning.org) and cloned via pINIT into the pCOND_Apr vector. 
Approximately 1 µg vector was electroporated into M. smegmatis and apramycin resistant clones were selected 
for integration with PCR, using the primers ideR_int Fw and ideR_int Rv. Additionally the presence of the pip 
promoter was confirmed with the primers Pip_Fw and Pip_Rv. One clone was selected and transformed with the 
integrative vector pFRA61.1 (obtained from Francesca Boldrin and Riccardo Manganelli, unpublished), contain-
ing the constitutively expressed Tet repressor TetR and the gene encoding the Pip repressor under the control of 
the PfurA102 promoter controlled by TetR, as well as a streptomycin resistance marker. This clone was used for the 
subsequent CAS experiments for detection of soluble siderophores. For this purpose, cells of the conditional ideR 
mutant were grown in 100 ml minimal medium (6% glycerol (v/v), 5 g L-asparagine and 5 g KH2PO4 per 1 liter 
of medium, pH 6.8 adjusted with NaOH) supplemented with 1.9 μg/ml ZnSO4 · 7H2O, 0.4 μg/ml MnSO4 · 5H2O, 
0.4 mg/ml MgSO4 · 7H2O, 25 μg/ml apramycin, 25 μg/ml streptomycin, and with different ATc concentrations. 
Soluble siderophore production was assessed every 24 hours by taking a 1 ml aliquot of the cultures and perform-
ing the CAS assay with the supernatant as described39.
Data availability. All data generated or analyzed during this study are included in this published article. The 
vectors are made accessible to the community by depositing them on Addgene.
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